RYSTIGGO

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 50474-981
  • Package NDC 50474-981-83
  • Application number BLA761286
  • SPL ID 5e8548a5-6c75-21e6-e063-6294a90a9cd6
  • SPL set ID 3c0eb8c2-c042-4954-b451-3baa77f5e6d1
  • UNII P7186074QC
  • RxCUI 2642288
  • RxCUI 2642294
  • RxCUI 2685614
  • RxCUI 2685615
  • RxCUI 2685616
  • RxCUI 2685617
  • RxCUI 2685618
  • RxCUI 2685619

What the source publishes

Labeler
UCB, Inc.
Active ingredients
ROZANOLIXIZUMAB
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:50474-981_5e8548a5-6c75-21e6-e063-6294a90a9cd6
{
  "name": "RYSTIGGO",
  "splId": "5e8548a5-6c75-21e6-e063-6294a90a9cd6",
  "labels": [
    {
      "setId": "3c0eb8c2-c042-4954-b451-3baa77f5e6d1",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c0eb8c2-c042-4954-b451-3baa77f5e6d1",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c0eb8c2-c042-4954-b451-3baa77f5e6d1"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "UCB, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, GLASS in 1 CARTON (50474-981-83)  / 3 mL in 1 VIAL, GLASS",
      "package_ndc": "50474-981-83",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240715"
    }
  ],
  "productId": "50474-981_5e8548a5-6c75-21e6-e063-6294a90a9cd6",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "50474-981",
  "deaSchedule": null,
  "genericName": "ROZANOLIXIZUMAB",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ROZANOLIXIZUMAB",
      "strength": "140 mg/mL"
    }
  ],
  "applicationNumber": "BLA761286",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240614",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000194004",
      "N0000194005"
    ],
    "unii": [
      "P7186074QC"
    ],
    "rxcui": [
      "2642288",
      "2642294",
      "2685614",
      "2685615",
      "2685616",
      "2685617",
      "2685618",
      "2685619"
    ],
    "spl_set_id": [
      "3c0eb8c2-c042-4954-b451-3baa77f5e6d1"
    ],
    "pharm_class_epc": [
      "Neonatal Fc Receptor Blocker [EPC]"
    ],
    "pharm_class_moa": [
      "Neonatal Fc Receptor Blockers [MoA]"
    ],
    "manufacturer_name": [
      "UCB, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50474-981_5e8548a5-6c75-21e6-e063-6294a90a9cd6"